Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sucampo Pharmaceuticals Inc (NASDAQ:SCMP)

14.93
Delayed Data
As of 3:59pm ET
 -0.87 / -5.54%
Today’s Change
9.59
Today|||52-Week Range
18.75
-13.68%
Year-to-Date
Why Valeant Pharmaceuticals (VRX) Could Be Positioned for a Slump
12:29pm / Zacks.com - Paid Partner Content
Theravance Stock Up on Fast Track Status for Velusetrag
9:32am / Zacks.com - Paid Partner Content
5 Stocks to Buy for Remarkable Earnings Growth in 2017
10:42am / Zacks.com - Paid Partner Content
5 Best Small-Cap Stocks for 2017
Dec 06 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Health Insurance Innovations, Aegean Marine Petrol...
10:02am / Zacks.com - Paid Partner Content
Bristol-Myers Reports Data from Opdivo Combination Studies
Dec 06 / Zacks.com - Paid Partner Content
Novartis (NVS) Zykadia Positive in Phase III ASCEND-4 Study
9:58am / Zacks.com - Paid Partner Content
GW Pharma (GWPH) Posts Narrower-than-Expected Q4 Loss
Dec 06 / Zacks.com - Paid Partner Content
Sage Therapeutics Stock Up on SAGE-547 Regulatory Update
9:58am / Zacks.com - Paid Partner Content
Acceleron, Celgene Present Myelodysplastic Syndromes Data
Dec 05 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close15.80
Today’s open15.75
Day’s range14.65 - 15.75
Volume1,109,756
Average volume (3 months)387,752
Market cap$721.9M
Dividend yield--
Data as of 3:59pm ET, 12/07/2016

Growth & Valuation

Earnings growth (last year)+151.72%
Earnings growth (this year)+25.72%
Earnings growth (next 5 years)+54.00%
Revenue growth (last year)+32.68%
P/E ratio51.5
Price/Sales5.16
Price/Book8.29

Competitors

 Today’s
change
Today’s
% change
ARDXArdelyx Inc-0.65-4.05%
MACKMerrimack Pharmaceut...-0.21-3.74%
VNDAVanda Pharmaceutical...-0.60-3.75%
CLCDCoLucid Pharmaceutic...-0.70-1.73%
Data as of 4:00pm ET, 12/07/2016

Financials

Next reporting dateMarch 14, 2017
EPS forecast (this quarter)$0.47
Annual revenue (last year)$153.2M
Annual profit (last year)$33.4M
Net profit margin21.79%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Peter S. Greenleaf
Chief Financial Officer
Andrew P. Smith
Corporate headquarters
Rockville, Maryland

Forecasts


Search for Jobs